Customer Guest
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Login | Register
Login | Register|Forgot password?
As of March 2026 39.91% is owned by Indian Promoters and 60.09% by Public. Top five Promoters holding highest number of shares of Eiko Lifesciences c...more...
In view of SEBI circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated 26th November 2018 and amendments thereto (the said Circular) we wish to info...more...
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter and year ended on 31st March 2026 receive...more...
As of February 2026 39.91% is owned by Indian Promoters and 60.09% by Public. Top five Promoters holding highest number of shares of Eiko Li...more...
Allotment of 6 25 000 Equity Shares and 29 50 000 Warrants on preferential basis under SEBI (ICDR) Regulations 2018 through Circulation on Tuesday 24...more...
The company reported standalone net profit of Rs 0.95 crore for the quarter ended December 31 2025 as compared to Rs 0.28 crore in the same ...more...
Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 ( List...more...
As of December 2025 37.17% is owned by Indian Promoters and 62.83% by Public. Top five Promoters holding highest number of shares of Eiko Li...more...
Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2026 inter alia to consider and...more...
Certificate under Regulation. 74(5) of SEBI DP Act 2018 for the Quarter ended 31st December 2025.more...
Combined e-voting results along with Scrutinizer Report.more...
Outcome of 01st Extra-Ordinary General Meeting of Eiko Lifesciences Limited held on 07th January 2026more...
The Promoter Group Entity M/s Lenus Finvest Private Limited received an adjudication order dated 05/01/2026 from SEBI for the alleged non-compliance ...more...
01st Extra-Ordinary General Meeting to be held on Wednesday 07th January 2026 for approval of Issue securities on preferential basis\r\nmore...
Press release for Acquisition of 51% in SSM Formulations Private Limitedmore...
The Company intends to raise funds by issuing 33 00 000 Warrants and 6 75 000 Equity Shares on a preferential basis at a price of Rs. 55.00 ...more...
Acquisition of 51% of Equity shares of M/s SSM Formulations Private Limited and making it as subsidiary of Eiko Lifesciences Limited once the Acquisi...more...
The Board considered and aprroved various agendas as per the attachmentmore...
Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/12/2025 inter alia to consider and...more...
BOARD MEETINGS Company Name : Paisalo Digital Date : 10-05-2026